TY  - GEN
AU  - Doshi,Jalpa A
AU  - Puckett,Justin T
AU  - Parmacek,Michael S
AU  - Rader,Daniel J
TI  - Prior Authorization Requirements for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Across US Private and Public Payers
SN  - 1941-7705
PY  - 2019///0729
KW  - Anticholesteremic Agents
KW  - economics
KW  - Biomarkers
KW  - blood
KW  - Cholesterol, LDL
KW  - Databases, Factual
KW  - Drug Costs
KW  - Dyslipidemias
KW  - Eligibility Determination
KW  - Humans
KW  - Medical Assistance
KW  - PCSK9 Inhibitors
KW  - Policy Making
KW  - Prior Authorization
KW  - Private Sector
KW  - Proprotein Convertase 9
KW  - metabolism
KW  - Serine Proteinase Inhibitors
KW  - United States
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/CIRCOUTCOMES.117.003939
ER  -